Hypoxia, hormones, and endothelial progenitor cells in hemangioma

Lymphatic Research and Biology

Volumn 5, Issue 4, 2007, Pages 237-243

  Chang, Edward I ^a   Chang, Eric I ^a   Thangarajah, Hariharan ^a   Hamou, Cynthia ^a   Gurtner, Geoffrey C ^a,b  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; OXYGEN; STROMAL CELL DERIVED FACTOR 1ALPHA; VASCULOTROPIN;

ANGIOGENESIS; CELL PROLIFERATION; CHILDHOOD CANCER; DISEASE COURSE; ENDOTHELIUM CELL; ESTROGEN ACTIVITY; HEMANGIOMA; HUMAN; HYPOXIA; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PUERPERIUM; REVIEW; STEM CELL; UPREGULATION;

ANIMALS; ANOXIA; CELL TRANSFORMATION, NEOPLASTIC; ENDOTHELIAL CELLS; ESTROGENS; FEMALE; HEMANGIOMA; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; INFANT; INFANT, NEWBORN; NEOVASCULARIZATION, PATHOLOGIC; PLACENTA; PREGNANCY; STEM CELLS;

EID: 38149062166     PISSN: 15396851     EISSN: None     Source Type: Journal    
DOI: 10.1089/lrb.2007.1014     Document Type: Review

References (48)

1. Drolet BA, Esterly NB, Frieden IJ. Hemangiomas in children. N Engl J Med 1999 1999;341:173-181.
2. Pratt AG. Birthmarks in infants. AMA Arch Derm Syphilol 1953;67:302-305.
3. Jacobs AH, Walton RG. The incidence of birthmarks in the neonate. Pediatrics 1976;58:218-222.
4. Bowers R, Graham E, Tomlinson K. The natural history of the strawberry nevus. Arch Dermatol 1969;82:667-680.
5. Margileth AM, Museles M. Cutaneous hemangiomas in children. Diagnosis and conservative management. JAMA 1965;194:523-526.
6. Enjolras O, Mulliken JB. The current management of vascular birthmarks. Pediatr Dermatol 1993;10:311-313.
7. Burton BK, Schulz CJ, Angle B, Burd LI. An increased incidence of haemangiomas in infants born following chorionic villus sampling (CVS). Prenat Diagn 1995;15:209-214.
8. Kaplan P, Normandin J, Jr., Wilson GN, Plauchu H, Lippman A, Vekemans M. Malformations and minor anomalies in children whose mothers had prenatal diagnosis: comparison between CVS and amniocentesis. Am J Med Genet 1990;37:366-370.
9. Los FJ, Noomen P, Vermeij-Keers C, Gaillard JL, Brandenburg H, Jahoda MG, Luider TM. Chorionic villus sampling and materno-fetal transfusions: an immunological pathogenesis of vascular disruptive syndromes? Prenat Diagn 1996;16:193-198.
10. Jansen MW, Brandenburg H, Wildschut HI, Martens AC, Hagenaars AM, Wladimiroff JW, in't Veld PA. The effect of chorionic villus sampling on the number of fetal cells isolated from maternal blood and on maternal serum alpha-fetoprotein levels. Prenat Diagn 1997;17:953-959.
11. Banks RE, Forbes MA, Searles J, Pappin D, Canas B, Rahman D, Kaufmann S, Walters CE, Jackson A, Eves P, Linton G, Keen J, Walker JJ, Selby PJ. Evidence for the existence of a novel pregnancy-associated soluble variant of the vascular endothelial growth factor receptor, Flt-1. Mol Hum Reprod 1998;4:377-386.
12. Clark DE, Smith SK, He Y, Day KA, Licence DR, Corps AN, Lammoglia R, Charnock-Jones DS. A vascular endothelial growth factor antagonist is produced by the human placenta and released into the maternal circulation. Biol Reprod 1998;59:1540-1548.
13. Hornig C, Barleon B, Ahmad S, Vuorela P, Ahmed A, Welch HA. Release and complex formation of soluble VEGFR-1 from endothelial cells and biological fluids. Lab Invest 2000;80:443-454.
14. North PE, Waner M, Mizeracki A,Mrak RE, Nicholas R, Kincannon , Suen JY, Mihm MC Jr. A unique microvascular phenotype shared by juvenile hemangiomas and human placenta. Arch Dermatol 2001;137:559-570.
15. North PE, Waner M, Mizeracki A, Mihm MC Jr. GLUT1: a newly discovered immunohistochemical marker for juvenile hemangiomas. Hum Pathol 2000;31:11-22.
16. Barnes CM, Huang S, Kaipainen A, Sanoudou D, Chen EJ, Eichler GS, Guo Y, Yu Y, Ingber DE, Mulliken JB, Beggs AH, Folkman J, Fishman SJ. Evidence by molecular profiling for a placental origin of infantile hemangioma. Proc Natl Acad Sci USA 27 2005;102:19097-19102.
17. Khan ZA, Melero-Martin JM, Wu X, Paruchuri S, Boscolo E, Mulliken JB, Bischoff J. Endothelial progenitor cells from infantile hemangioma and umbilical cord blood display unique cellular responses to endostatin. Blood 2006;108:915-921.
18. Bauland CG, van Steensel MA, Steijlen PM, Rieu PN, Spauwen PH. The pathogenesis of hemangiomas: a review. Plast Reconstr Surg 2006;117:29e-35e.
19. Bree AF, Siegfried E, Sotelo-Avila C, Nahass G. Infantile hemangiomas: speculation on placental trophoblastic origin. Arch Dermatol 2001;137:573-577.
20. Pittman KM, Losken HW, Kleinman ME, Marcus JR, Blei F, Gurtner GC, Marchuk DA. No evidence for maternal-fetal microchimerism in infantile hemangioma: a molecular genetic investigation. J Invest Dermatol 2006;126:2533-2538.
21. Holmdahl K. Cutaneous vascular lesions in premature and mature infants. Acta Paediatrica 1995;44:370-379.
22. Amir J, Metzker A, Krikler R, Reisner SH. Strawberry hemangioma in preterm infants. Pediatr Dermatol 1986;3:331-332.
23. Hemangioma Investigator Group, Haggstrom AN, Drolet BA, Baselga E, Chamlin SL, Garzon MC, Horil KA, Lucky AW, Mancini AJ, Metry DW, Newell B, Nopper AJ, Frieden IJ. Prospective study of infantile hemangiomas: demographic, prenatal, and perinatal characteristics. J Pediatr 2007;150:291-294.
24. Peng Q, Liu W, Tang Y, Yu S. The establishment of the hemangioma model in nude mouse. J Pediatr Surg 2005;40:1167-1172.
25. Dubois-Stringfellow N, Kolpack-Martindale L, Bautch VL, Azizkhan RG. Mice with hemangiomas induced by transgenic endothelial cells. A model for the Kasabach-Merritt syndrome. Am J Pathol 1994;144:796-806.
26. Liekens S, Verbeken E, Vandeputte M, De Clercq E, Neyts J . A novel animal model for hemangiomas: inhibition of hemangioma development by the angiogenesis inhibitor TNP-470. Cancer Res 1999;59:2376-2383.
27. Walter JW, Blei F, Anderson JL, Orlow SJ, Speer MC, Marchuk DA. Genetic mapping of a novel familial form of infantile hemangioma. Am J Med Genet 1999;82:77-83.
28. Blei F, Walter J, Orlow SJ, Marchuk DA. Familial segregation of hemangiomas and vascular malformations as an autosomal dominant trait. Arch Dermatol 1998;134:718-722.
29. Berg JN, Walter JW, Thisanagayam U, Evans M, Biel F, Waner M, Diamond AG, Marchuk DA, Porteous ME. Evidence for loss of heterozygosity of 5q in sporadic haemangiomas: are somatic mutations involved in haemangioma formation? J Clin Pathol 2001;54:249-252.
30. Cheung DS, Warman ML, Mulliken JB. Hemangioma in twins. Ann Plast Surg 1997;38:269-274.
31. Nguyen VA, Furhapter C, Romani N, Weber F, Sepp N. Infantile hemangioma is a proliferation of beta 4-negative endothelial cells adjacent to HLA-DR-positive cells with dendritic cell morphology. Hum Pathol 2004;35:739-744.
32. Folkman J. Seminars in Medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis. N Engl J Med 1995;333:1757-1763.
33. Folkman J, Klagsbrun M. Angiogenic factors. Science 1987;235:442-447.
34. Tepper OM, Capla JM, Galiano RD, Ceradini DJ, Callaghan MJ, Kleinman ME, Gurtner GC. Adult vasculogenesis occurs through in situ recruitment, proliferation, and tubulization of circulating bone marrow-derived cells. Blood 2005;105:1068-1077.
35. Kleinman ME, Tepper OM, Capla JM, Bhatt KA, Ceradini Dj, Galiano RD, Blei F, Levine Jp, Gurtner GC. Increased circulating AC133+ CD34+ endothelial progenitor cells in children with hemangioma. Lymphat Res Biol 2003;1:301-307.
36. Yu Y, Flint AF, Mulliken JB, Wu JK, Bischoff J. Endothelial progenitor cells in infantile hemangioma. Blood 2004;103:1373-1375.
37. Boye E, Yu Y, Paranya G, Mulliken JB, Olsen BR, Bischoff J. Clonality and altered behavior of endothelial cells from hemangiomas. J Clin Invest 2001;107:745-752.
38. Pugh CW, Ratcliffe PJ. Regulation of angiogenesis by hypoxia: role of the HIF system. Nat Med 2003;9:677-684.
39. Ceradini DJ, Kulkarni AR, Callaghan MJ, Tepper OM, Bastidas N, Kleinman ME, Capla JM, Galiano RD, Levine JP, Gurtner GC . Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat Med 2004;10:858-864.
40. Rathmell WK, Acs G, Simon MC. HIF transcription factor expression and induction of hypoxic response genes in a retroperitoneal angiosarcoma. Anticancer Res 2004;24:167-169.
41. Kimura S, Kitadai Y, Tanaka S,Kuwai T, Hihara J, Toshida K, Toge T, Chayama K. Expression of hypoxia-inducible factor (HIF)-1alpha is associated with vascular endothelial growth factor expression and tumour angiogenesis in human oesophageal squamous cell carcinoma. Eur J Cancer 2004;40:1904-1912.
42. Olenyuk BZ, Zhang GJ, Klco JM, Nickols NG, Kaelin WG Jr, Dervan PB. Inhibition of vascular endothelial growth factor with a sequence-specific hypoxia response element antagonist. Proc Natl Acad Sci USA 2004;101:16768- 16773.
43. Kleinman ME, Churgin SS, Blechman KM, Chang EI, Ceradini DJ, Tepper OM, Gurtner GC. Hypoxia induced mediators of stem/progenitor cell trafficking in children with hemangioma. Arterioscler Thromb Vasc Biol 2007;27:2664-2670.
44. Venkov CD, Rankin AB, Vaughan DE. Identification of authentic estrogen receptor in cultured endothelial cells. A potential mechanism for steroid hormone regulation of endothelial function. Circulation 1996;94:727-733.
45. Razandi M, Pedram A, Levin ER. Estrogen signals to the preservation of endothelial cell form and function. J Biol Chem 2000;275:38540-38546.
46. Spyridopoulos I, Sullivan AB, Kearney M,Isner JM, Losordo DW. Estrogen-receptor-mediated inhibition of human endothelial cell apoptosis. Estradiol as a survival factor. Circulation 1997;95:1505-1514.
47. Xiao X, Hong L, Sheng M. Promoting effect of estrogen on the proliferation of hemangioma vascular endothelial cells in vitro. J Pediatr Surg 1999;34:1603-1605.
48. Sasaki GH, Pang CY, Wittliff JL. Pathogenesis and treatment of infant skin strawberry hemangiomas: clinical and in vitro studies of hormonal effects. Plast Reconstr Surg 1984;73:359-370.